| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $475.7M | $401.2M | $325.1M |
| YoY Revenue Growth % | +18.6% | +23.4% | — |
| Gross Profit | $400.5M | $338.6M | — |
| Gross Margin % | 84.2% | 84.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $66.5M | $56.9M | $33.2M |
| Operating Margin % | 14.0% | 14.2% | 10.2% |
| Net Income (GAAP) | $78.3M | -$283.0M | -$81.1M |
| EBITDA (Normalized) | $77.1M | $63.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $173.5M | $132.2M | $102.1M |
| Capital Expenditures (CapEx) | $13.2M | $8.6M | — |
| Free Cash Flow (FCF) | $160.3M | $123.6M | $102.1M |
| FCF Margin % | 33.7% | 30.8% | 31.4% |
| Return on Invested Capital (ROIC %) | 14.6% | 31.1% | — |
| Cash & Short-Term Equivalents | $124.5M | $191.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $484.3M | $336.0M | — |